Two studies found that specific anti-obesity therapies can also achieve a significant reduction in high blood pressure. Medical experts consider this new finding to be a significant advance in medicine.
Tirzepatide is sold under various brand names to patients with obesity and people suffering from type 2 diabetes. The strongest effect was observed in the subjects who received a dose of 15 milligrams. After a period of nine months, a reduction in blood pressure of up to 8.0 mmHg was observed.